The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Role of osteopontin in the pathophysiology of cancer
Open accessAbstract
Osteopontin (OPN) is a multifunctional cytokine that impacts cell proliferation, survival, drug resistance, invasion, and stem like behavior. Due to its critical involvement in regulating cellular functions, its aberrant expression and/or splicing is functionally responsible for undesirable alterations in disease pathologies, specifically cancer. It is implicated in promoting invasive and metastatic progression of many carcinomas. Due to its autocrine and paracrine activities OPN has been shown to be a crucial mediator of cellular cross talk and an influential factor in the tumor microenvironment. OPN has been implicated as a prognostic and diagnostic marker for several cancer types. It has also been explored as a possible target for treatment. In this article we hope to provide a broad perspective on the importance of OPN in the pathophysiology of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wang, X., Li, J., Yan, M., Liu, L., Jia, D., Qin, G., Lin, H., He, X., Li, J., & Yao, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055714 · Cited by 98
RetractedCerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Eta-1 (Osteopontin): An Early Component of Type-1 (Cell-Mediated) Immunity
Ashkar, S., Weber, G. F., Panoutsakopoulou, V., Sanchirico, M. E., Jansson, M., Zawaideh, S., Rittling, S. R., Denhardt, D. T., Glimcher, M. J., & Cantor, H. (2000) · Science · doi:10.1126/science.287.5454.860 · Cited by 1,125
Sodek, J., Ganss, B., & McKee, M. D. (2000) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411000110030101 · Cited by 993
Isolation and characterization of two sialoproteins present only in bone calcified matrix
Franzén, A., & Heinegård, D. (1985) · Biochemical Journal · doi:10.1042/bj2320715 · Cited by 559
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
Ding, Z., Wu, C.-J., Chu, G. C., Xiao, Y., Ho, D., Zhang, J., Perry, S. R., Labrot, E. S., Wu, X., Lis, R., et al. (2011) · Nature · doi:10.1038/nature09677 · Cited by 515
Systemic Endocrine Instigation of Indolent Tumor Growth Requires Osteopontin
McAllister, S. S., Gifford, A. M., Greiner, A. L., Kelleher, S. P., Saelzler, M. P., Ince, T. A., Reinhardt, F., Harris, L. N., Hylander, B. L., Repasky, E. A., et al. (2008) · Cell · doi:10.1016/j.cell.2008.04.045 · Cited by 431
Coppola, D., Szabo, M., Boulware, D., Muraca, P., Alsarraj, M., Chambers, A. F., & Yeatman, T. J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1405-2 · Cited by 341
Identification of Osteopontin as a Novel Marker for Early Hepatocellular Carcinoma
Shang, S., Plymoth, A., Ge, S., Feng, Z., Rosen, H. R., Sangrajrang, S., Hainaut, P., Marrero, J. A., & Beretta, L. (2012) · Hepatology · doi:10.1002/hep.24703 · Cited by 322
Vargas-Roig, L. M., Gago, F. E., Tello, O. M., Aznar, J. C., & Ciocca, D. R. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19981023)79:5<502::aid-ijc10>3.0.co;2-3 · Cited by 302
Singhal, H., Bautista, D., Tonkin, K. S., O’Malley, F. P., Tuck, A. B., Chambers, A. F., & Harris, J. F. (1997) · PubMed · Cited by 285
Chakraborty, G., Jain, S., & Kundu, G. C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2126 · Cited by 266
Bellahcène, A., & CASTRONOVO, V. (1995) · Europe PMC (PubMed Central) · Cited by 240
Craig, A. M., Smith, J. H., & Denhardt, D. T. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60584-8 · Cited by 238
Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy
Boyerinas, B., Zafrir, M., Yesilkanal, A. E., Price, T. T., Hyjek, E. M., & Sipkins, D. A. (2013) · Blood · doi:10.1182/blood-2012-12-475483 · Cited by 231
Laffón, A., García-Vicuña, R., Humbría, A., Postigo, A. A., Corbí, A. L., de Landázuri, M. O., & Sánchez-Madrid, F. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115338 · Cited by 201
Shinohara, M. L., Kim, H.-J., Kim, J.-H., Garcia, V. A., & Cantor, H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802301105 · Cited by 193
Tuck, A. B., Arsenault, D., O’Malley, F. P., Hota, C., Ling, M. C., Wilson, S. M., & Chambers, A. F. (1999) · Oncogene · doi:10.1038/sj.onc.1202799 · Cited by 191
Boissy, P., Andersen, T. L., Abdallah, B. M., Kassem, M., Plesner, T., & Delaissé, J.-M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0651 · Cited by 190
Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis
Mi, Z., Bhattacharya, S. D., Kim, V. M., Guo, H., Talbot, L. J., & Kuo, P. C. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr009 · Cited by 179
An osteopontin splice variant induces anchorage independence in human breast cancer cells
He, B., Mirza, M., & Weber, G. F. (2006) · Oncogene · doi:10.1038/sj.onc.1209248 · Cited by 178
Rangaswami, H., Bulbule, A., & Kundu, G. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404674200 · Cited by 175
Kale, S., Raja, R., Thorat, D., Soundararajan, G., Patil, T. V., & Kundu, G. C. (2013) · Oncogene · doi:10.1038/onc.2013.184 · Cited by 168
Osteopontin in macrophage function
Rittling, S. R. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001839 · Cited by 168
Serial Plasma Osteopontin Levels Have Prognostic Value in Metastatic Breast Cancer
Bramwell, V. H. C., Doig, G. S., Tuck, A. B., Wilson, S. M., Tonkin, K. S., Tomiak, A., Perera, F., Vandenberg, T. A., & Chambers, A. F. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2354 · Cited by 165
Suzuki, K., Zhu, B., Rittling, S. R., Denhardt, D. T., Goldberg, H. A., McCulloch, C. A., & Sodek, J. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.8.1486 · Cited by 161
Raja, R., Kale, S., Thorat, D., Soundararajan, G., Lohite, K., Mane, A. D., Karnik, S. V., & Kundu, G. C. (2013) · Oncogene · doi:10.1038/onc.2013.171 · Cited by 149
Rao, G., Wang, H., Li, B., Huang, L., Xue, D., Wang, X., Jin, H., Wang, J., Zhu, Y., Lu, Y., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2788 · Cited by 149
Tuck, A. B., Elliott, B. E., Hota, C., Tremblay, E., & Chambers, A. F. (2000) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(20000901)78:3<465::aid-jcb11>3.0.co;2-c · Cited by 145
Osteopontin‐c is a selective marker of breast cancer
Mirza, M., Shaughnessy, E., Hurley, J. K., Vanpatten, K. A., Pestano, G. A., He, B., & Weber, G. F. (2007) · International Journal of Cancer · doi:10.1002/ijc.23204 · Cited by 139
Das, S., Harris, L. G., Metge, B. J., Liu, S., Riker, A. I., Samant, R. S., & Shevde, L. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.021949 · Cited by 132
Self-citationTuck, A. B., Hota, C., Wilson, S. M., & Chambers, A. F. (2003) · Oncogene · doi:10.1038/sj.onc.1206209 · Cited by 128
Denhardt, D., Mistretta, D., Chambers, A., Krishna, S., Porter, J., Raghuram, S., & Rittling, S. (2004) · Clinical and Experimental Metastasis · doi:10.1023/a:1022550721404 · Cited by 115
Samant, R. S., Clark, D. W., Fillmore, R. A., Cicek, M., Metge, B. J., Chandramouli, K. H., Chambers, A. F., Casey, G., Welch, D. R., & Shevde, L. A. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-6 · Cited by 115
Self-citationKhan, S. A., Cook, A. C., Kappil, M., Günthert, U., Chambers, A., Tuck, A., & Denhardt, D. (2006) · Clinical and Experimental Metastasis · doi:10.1007/s10585-006-9007-0 · Cited by 111
The aldehyde dehydrogenase enzyme 7A1 is functionally involved in prostate cancer bone metastasis
van den Hoogen, C., van der Horst, G., Cheung, H., Buijs, J. T., Pelger, R. C. M., & van der Pluijm, G. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9395-7 · Cited by 109
Pre- and post-translational regulation of osteopontin in cancer
Anborgh, P. H., Mutrie, J. C., Tuck, A. B., & Chambers, A. F. (2011) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-011-0130-6 · Cited by 108
Poruk, K. E., Firpo, M. A., Scaife, C. L., Adler, D. G., Emerson, L. L., Boucher, K. M., & Mulvihill, S. J. (2013) · Pancreas · doi:10.1097/mpa.0b013e31825e354d · Cited by 106
Cooperative Unfolding of Compact Conformations of the Intrinsically Disordered Protein Osteopontin
Kurzbach, D., Platzer, G., Schwarz, T. C., Henen, M. A., Konrat, R., & Hinderberger, D. (2013) · Biochemistry · doi:10.1021/bi400502c · Cited by 105
Cook, A. C., Tuck, A. B., McCarthy, S. M., Turner, J. G., Irby, R., Bloom, G. C., Yeatman, T. J., & Chambers, A. F. (2005) · Molecular Carcinogenesis · doi:10.1002/mc.20105 · Cited by 105
Das, R., Mahabeleshwar, G. H., & Kundu, G. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310256200 · Cited by 103
Role of the Integrin-Binding Protein Osteopontin in Lymphatic Metastasis of Breast Cancer
Allan, A. L., George, R., Vantyghem, S. A., Lee, M. W., Hodgson, N. C. F., Engel, C. J., Holliday, R. L., Girvan, D. P., Scott, L. A., Postenka, C. O., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051152 · Cited by 102
Ets Gene PEA3 Cooperates with β-Catenin-Lef-1 and c-Jun in Regulation of Osteopontin Transcription
El‐Tanani, M., Platt-Higgins, A. M., Rudland, P. S., & Campbell, F. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311131200 · Cited by 100
Wang, Y., Yan, W., Lu, X., Qian, C., Zhang, J., Li, P., Shi, L., Zhao, P., Fu, Z., Pu, P., et al. (2011) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2011.03.005 · Cited by 99
Osteopontin-c Splicing Isoform Contributes to Ovarian Cancer Progression
Tilli, T. M., Franco, V. F., Robbs, B. K., et al. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0463 · Cited by 99
Atai, N. A., Bansal, M., Lo, C., Bosman, J., Tigchelaar, W., Bosch, K. S., Jonker, A., Hamer, P. C. D. W., Troost, D., McCulloch, C. A., et al. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03335.x · Cited by 97
Desai, B., Ma, T., & Chellaiah, M. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709401200 · Cited by 95
Osteopontin Knockdown Suppresses Tumorigenicity of Human Metastatic Breast Carcinoma, MDA-MB-435
Shevde, L. A., Samant, R. S., Paik, J. C., Metge, B. J., Chambers, A. F., Casey, G., Frost, A. R., & Welch, D. R. (2006) · Clinical & Experimental Metastasis · doi:10.1007/s10585-006-9013-2 · Cited by 93
Self-citationFurger, K. A., Allan, A. L., Wilson, S. M., Hota, C., Vantyghem, S. A., Postenka, C. O., Al‐Katib, W., Chambers, A. F., & Tuck, A. B. (2003) · PubMed · Cited by 92
Yuen, H., Chan, K.-K., Grills, C., Murray, J. T., Platt-Higgins, A. M., Eldin, O. S., O'Byrne, K. J., Janne, P. A., Fennell, D. A., Johnston, P. G., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2035 · Cited by 89
Hollevoet, K., Nackaerts, K., Gosselin, R., Wever, W. D., Bosquée, L., Vuyst, P. D., Germonpré, P. R., Kellen, E., Legrand, C., Kishi, Y., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182272294 · Cited by 84
Jain, S., Chakraborty, G., & Kundu, G. C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0661 · Cited by 83
Kumar, V., Behera, R., Lohite, K., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1470 · Cited by 82
Zhang, R., Pan, X., Huang, Z., Weber, G. F., & Zhang, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023831 · Cited by 81
Lu, D., Yeh, W., Huang, S.-M., Tang, C., Lin, H., & Chou, S.-J. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos262 · Cited by 76
Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer
Shojaei, F., Scott, N., Kang, X., Lappin, P. B., Fitzgerald, A. A., Karlicek, S., Simmons, B. H., Wu, A., Lee, J. H., Bergqvist, S., et al. (2012) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-31-26 · Cited by 71
Mentor-Marcel, R. A., Lamartiniere, C. A., Eltoum, I. A., Greenberg, N. M., & Elgavish, A. (2005) · Journal of Nutrition · doi:10.1093/jn/135.5.989 · Cited by 71
Combined Serum Mesothelin and Plasma Osteopontin Measurements in Malignant Pleural Mesothelioma
Cristaudo, A., Bonotti, A., Simonini, S., Vivaldi, A., Guglielmi, G., Ambrosino, N., Chella, A., Lucchi, M., Mussi, A., & Foddis, R. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31821e1c08 · Cited by 69
Torres‐Martín, M., Lassaletta, L., San-Román-Montero, J., de Campos, J. M., Isla, A., Gavilán, J., Meléndez, B., Pinto, G. R., Burbano, R. M. R., Castresana, J. S., et al. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1798 · Cited by 69
Sharif, S. A., Du, X., Myles, T., Song, J. J., Elizabeth, P., Lee, D. M., Goodman, S. B., Nagashima, M., Morser, J., Robinson, W. H., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24814 · Cited by 69
Platzer, G., Schedlbauer, A., Chemelli, A., Ozdowy, P., Coudevylle, N., Auer, R., Kontaxis, G., Hartl, M., Miles, A. J., Wallace, B. A., et al. (2011) · Biochemistry · doi:10.1021/bi200291e · Cited by 68
Ahmed, M., & Kundu, G. C. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-101 · Cited by 67
Hedgehog Signaling: Networking to Nurture a Promalignant Tumor Microenvironment
Harris, L. G., Samant, R. S., & Shevde, L. A. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0175 · Cited by 66
Self-citationYamaguchi, Y., Shao, Z., Sharif, S. A., Du, X., Myles, T., Merchant, M. J., Harsh, G. R., Glantz, M., Recht, L. D., Morser, J., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.362954 · Cited by 65
Regulation of Erk1/2 activation by osteopontin in PC3 human prostate cancer cells
Robertson, B. W., Bonsal, L., & Chellaiah, M. A. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-260 · Cited by 65
Mitra, A., Menezes, M. E., Pannell, L. K., Mulekar, M. S., Honkanen, R. E., Shevde, L. A., & Samant, R. S. (2012) · Oncogene · doi:10.1038/onc.2011.623 · Cited by 64
Samanna, V., Wei, H., Ego-Osuala, D., & Chellaiah, M. A. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.03.022 · Cited by 63
Thoms, J., Pra, A. D., Anborgh, P. H., Christensen, E. N., Fleshner, N. E., Ménard, C. M., Chadwick, K., Milosevic, M., Catton, C., Pintilie, M., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.345 · Cited by 62
Osteopontin Stimulates Preneoplastic Cellular Proliferation Through Activation of the MAPK Pathway
Luo, X., Ruhland, M. K., Pazolli, E., Lind, A. C., & Stewart, S. A. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0472 · Cited by 62
Shevde, L. A., Metge, B. J., Mitra, A., Xi, Y., Ju, J., KING, J. A. C., & Samant, R. S. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00821.x · Cited by 60
Self-citationPrognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer
Pang, H., Lu, H., Song, H., Meng, Q., Zhao, Y., Liu, N., Lan, F., Liu, Y., Yan, S., Dong, X., et al. (2013) · Cancer Epidemiology · doi:10.1016/j.canep.2013.08.005 · Cited by 59
Hsieh, Y., Juliana, M. M., Hicks, P. H., Feng, G., Elmets, C. A., Liaw, L., & Chang, P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1002 · Cited by 59
Osteopontin—An important downstream effector of S100A4‐mediated invasion and metastasis
Berge, G., Pettersen, S., Grotterød, I., Bettum, I. J., Boye, K., & Mælandsmo, G. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25735 · Cited by 57
Hedgehog Signaling Induced by Breast Cancer Cells Promotes Osteoclastogenesis and Osteolysis
Das, S., Samant, R. S., & Shevde, L. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.174920 · Cited by 56
Self-citationCreaney, J., Yeoman, D., Musk, A. W., et al. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.02.007 · Cited by 54
Loss of Tumor Suppressor Merlin in Advanced Breast Cancer Is due to Post-translational Regulation
Morrow, K. A., Das, S., Metge, B. J., Ye, K., Mulekar, M. S., Tucker, J. A., Samant, R. S., & Shevde, L. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.250035 · Cited by 53
Self-citationUpregulation of Drug Transporter Expression by Osteopontin in Prostate Cancer Cells
Hsieh, I., Huang, W.-H., Liou, H., Chuang, W., Yang, R., & Fu, W. (2013) · Molecular Pharmacology · doi:10.1124/mol.112.082339 · Cited by 53
Beclin1-induced Autophagy Abrogates Radioresistance of Lung Cancer Cells by Suppressing Osteopontin
Chang, S.-H., Minai‐Tehrani, A., Shin, J., Park, S. J., Kim, J., Yu, K., Hong, S., Hong, C., Lee, K.-H., Beck, G. R., et al. (2012) · Journal of Radiation Research · doi:10.1269/jrr.11148 · Cited by 52
Thorsen, S. B., Lundberg, M., Villablanca, A., Christensen, S. L., Belling, K., Nielsen, B. S., Knowles, M., Gee, N., Nielsen, H. J., Brünner, N., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-253 · Cited by 52
Schultz, J., Lorenz, P., Ibrahim, S. M., Kundt, G., Gross, G., & Kunz, M. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20452 · Cited by 52
Osteopontin Induction of Hyaluronan Synthase 2 Expression Promotes Breast Cancer Malignancy
Cook, A. C., Chambers, A. F., Turley, E. A., & Tuck, A. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602694200 · Cited by 49
Osteopontin-Enhanced Hepatic Metastasis of Colorectal Cancer Cells
Huang, J., Pan, C., Hu, H., Zheng, S. S., & Ding, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047901 · Cited by 49
Nonclassical hedgehog‐gli signaling and its clinical implications
Shevde, L. A., & Samant, R. S. (2013) · International Journal of Cancer · doi:10.1002/ijc.28424 · Cited by 47
Self-citationRavindranath, A., Yuen, H.-F., Chan, K.-K., Grills, C., Fennell, D. A., Lappin, T. R., & El-Tanani, M. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.269 · Cited by 46 · cited 2×
“…have implicated OPN to impact signaling via hyaluronan synthase 2 (Cook et al., 2006), Wnt-β-catenin-Tcf-4 (T-cell factor4/ lymphoid enhancer factor1) signaling (Ravindranath et al., 2011), p70S6K/mTOR phosphorylation (Ahmed and Kundu, 2010), Src and Hsp90-dependent pathways (Mutrie et al., 2011).”
BackgroundHedley, B. D., Welch, D. R., Allan, A. L., Al‐Katib, W., Dales, D. W., Postenka, C. O., Casey, G., MacDonald, I. C., & Chambers, A. F. (2008) · International Journal of Cancer · doi:10.1002/ijc.23542 · Cited by 46
Pai, M., Kuo, Y., Chiang, E. I., & Tang, F. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511005307 · Cited by 44
Tilli, T. M., Thuler, L. C. S., Matos, A. D. R., Coutinho‐Camillo, C. M., Soares, F. A., da Silva, E. A., Neves, A. F., Goulart, L. R., & Gimba, E. R. P. (2011) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2011.09.014 · Cited by 44
Merlin: The wizard requires protein stability to function as a tumor suppressor
Morrow, K. A., & Shevde, L. A. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.06.005 · Cited by 43
Self-citationLi, N. Y., Weber, C. E., Wai, P. Y., Cuevas, B. D., Zhang, J., Kuo, P. C., & Mi, Z. (2013) · Surgery · doi:10.1016/j.surg.2013.05.012 · Cited by 43
Osteopontin Contributes to TGF-β1 Mediated Hepatic Stellate Cell Activation
Xiao, X., Yi, G., Gu, Y., Zhao, L., Chu, J., Zhou, J., Cai, X., Zhang, H., Xu, L., Nie, Y., et al. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2248-7 · Cited by 41
Wu, J., Pungaliya, P., Kraynov, E. A., & Bates, B. (2011) · Biomarkers · doi:10.3109/1354750x.2011.643485 · Cited by 40
Chen, Y., Liu, H., Wu, W., Li, Y., & Li, J. (2013) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-32-45 · Cited by 40
Yasutan, H. C., Tsukasaki, K., Takahashi, Y., Oguma, S., Harigae, H., Ishii, N., Zhang, J., Fukumoto, M., & Hattori, T. (2011) · Leukemia Research · doi:10.1016/j.leukres.2011.05.011 · Cited by 39
Control of the Human Osteopontin Promoter by ERRα in Colorectal Cancer
Boudjadi, S., Bernatchez, G., Beaulieu, J., & Carrier, J. C. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.03.021 · Cited by 38
Liu, J., Xu, K., Chase, M., Ji, Y., Logan, J. K., & Buchsbaum, R. J. (2012) · Journal of Cell Science · doi:10.1242/jcs.089466 · Cited by 37
Hedgehog Signaling in Tumor Cells Facilitates Osteoblast-Enhanced Osteolytic Metastases
Das, S., Tucker, J. A., Khullar, S., Samant, R. S., & Shevde, L. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034374 · Cited by 36
Self-citationEffects of osteopontin inhibition on radiosensitivityof MDA-MB-231 breast cancer cells
Hahnel, A., Wichmann, H., Kappler, M., Kotzsch, M., Vordermark, D., Taubert, H. W., & Bache, M. (2010) · Radiation Oncology · doi:10.1186/1748-717x-5-82 · Cited by 36
Felten, M. K., Khatab, K., Knoll, L., Schettgen, T., Müller-Berndorff, H., & Kraus, T. (2013) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-013-0853-1 · Cited by 35
Chuang, C.-Y., Chang, H., Lin, P., Sun, S., Chen, P., Lin, Y.-Y., Sheu, G., Ko, J., Hsu, S., & Chang, J. T. (2011) · Gene · doi:10.1016/j.gene.2011.10.019 · Cited by 33
BRCA1 Suppresses Osteopontin-mediated Breast Cancer
El‐Tanani, M., Campbell, F. C., Crowe, P., Erwin, P. J., Harkin, D. P., Pharoah, P. D. P., Ponder, B. A. J., & Rudland, P. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604403200 · Cited by 33
Osteopontin-a alters glucose homeostasis in anchorage-independent breast cancer cells
Shi, Z., Mirza, M., Wang, B., Kennedy, M. A., & Weber, G. F. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.10.008 · Cited by 31
Sun, J., Feng, A., Chen, S., Zhang, Y., Xie, Q., Yang, M., Shao, Q., Liu, J., Yang, Q., Kong, B., et al. (2013) · Cellular and Molecular Immunology · doi:10.1038/cmi.2012.67 · Cited by 29
Chang, P., Cao, M., & Hicks, P. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg138 · Cited by 28
Expression of osteopontin and HGF/Met in adult soft tissue tumors
Bramwell, V. H. C., Tuck, A. B., Wilson, S. M., et al. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.12.2166 · Cited by 26
Loss of RUNX3 increases osteopontin expression and promotes cell migration in gastric cancer
Cheng, H., Liu, Y., Shan, Y., Huang, C., Lin, F., Lin, L.-C., Lee, L., Tsai, C., Hsiao, M., & Lu, P. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt218 · Cited by 24
The osteopontin-c splice junction is important for anchorage-independent growth
Shen, H., & Weber, G. F. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.21997 · Cited by 20
SPP1 promoter polymorphisms and glioma risk in a Chinese Han population
Chen, J., Wu, Q., Lu, Y., Xu, T., Huang, Y., Ribas, J., Ni, X., Hu, G., Huang, F., Zhou, L., et al. (2010) · Journal of Human Genetics · doi:10.1038/jhg.2010.48 · Cited by 20
EGFR expression is linked to osteopontin and Nf-κB signaling in clear cell renal cell carcinoma
Matušan‐Ilijaš, K., Damante, G., Fabbro, D., Đorđević, G., Hadžisejdić, I., Grahovac, M., Avirović, M., Grahovac, B., Jonjić, N., & Lučin, K. (2012) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0889-9 · Cited by 18
Minai‐Tehrani, A., Chang, S.-H., Park, S. B., & Cho, M. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1483 · Cited by 17
Minai‐Tehrani, A., Chang, S.-H., Kwon, J., Hwang, S., Kim, J., Shin, J., Yu, K., Park, S. J., Jiang, H., Kim, J., et al. (2012) · Cellular Oncology · doi:10.1007/s13402-012-0107-3 · Cited by 17
Chang, W., Yang, H., Cheng, H., Chuang, C., Lu, P., & Sheu, B. (2011) · Helicobacter · doi:10.1111/j.1523-5378.2011.00832.x · Cited by 17
Plasma osteopontin concentrations in patients with cutaneous melanoma
Filia, A., Elliott, F., Wind, T. C., FIELD, S., DAVIES, J., Kukalizch, K., Randerson‐Moor, J. A., Harland, M., Bishop, D. T., Banks, R. E., et al. (2013) · Oncology Reports · doi:10.3892/or.2013.2666 · Cited by 17
Hsieh, Y., Juliana, M. M., Ho, K., Kuo, H., van der Heyde, H., Elmets, C. A., & Chang, P. (2011) · International Journal of Cancer · doi:10.1002/ijc.26359 · Cited by 13
Matricellular proteins osteopontin and osteonectin/SPARC in pancreatic carcinoma
Delany, A. M. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.1.12452 · Cited by 11
Etiz, D., Ataizi, F. C., Bayman, E., Akçay, M., Açıkalın, M. F., Çolak, E., & Çiftçi, E. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.9.5175 · Cited by 9
Hsieh, Y., van der Heyde, H., Oh, E., Guan, J., & Chang, P. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22108 · Cited by 8
Cited by
Extracellular matrix structure
Theocharis, A. D., Skandalis, S. S., Gialeli, C., & Karamanos, N. K. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.001 · Cited by 2,598
The extracellular matrix in breast cancer
Insua-Rodríguez, J., & Oskarsson, T. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.017 · Cited by 470
Revisiting the matricellular concept
Murphy-Ullrich, J. E., & Sage, E. H. (2014) · Matrix Biology · doi:10.1016/j.matbio.2014.07.005 · Cited by 392
The role of osteopontin in the progression of solid organ tumour
Zhao, H., Chen, Q., Alam, A., Cui, J., Suen, K. C., Soo, A. P., Eguchi, S., Gu, J., & Ma, D. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0391-6 · Cited by 371
The role of CXCR4 in multiple myeloma: Cells’ journey from bone marrow to beyond
Ullah, T. R. (2019) · Journal of Bone Oncology · doi:10.1016/j.jbo.2019.100253 · Cited by 141
Metadata
- Authors
- Shevde, L. A., & Samant, R. S.
- Venue
- Matrix Biology
- Publisher
- Elsevier BV
- Published
- 2014-07
- Volume
- 37
- Pages
- 131-141
- ISSN
- 0945-053X (ISSN-L)
- OpenAlex
- W2001165015
- Cited by
- 263
- References
- 116
- FWCI
- 17.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.